July 2018

The Medicaid and CHIP Payment and Access Commission (MACPAC) recently released their June 2018 Report to Congress on Medicaid and…

In June 2018, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent its second…

With less than a year into New Jersey’s “gift” ban regulation, Attorney General Gurbir Grewal has signaled that changes to an…

A report recently released by the United States Government Accountability Office (GAO) reveals that some contracting practices for…

Recently, the Mayo Clinic published a paper on the importance of economic trade-offs in cancer drug pricing. The paper, written by…

Buried in the proposed 2019 Medicare Physician Fee Schedule, CMS announced potential changes to evaluation and management (E/M)…

On June 19, 2018, the Senate Aging Committee held a hearing to examine the progress of Alzheimer’s diagnosis, prevention,…

On the evening of July 16, the House passed a sweeping over-the-counter (OTC) drug regulation reform bill, bringing the first…

Recently, Canadian news outlet The Globe and Mail reported that British Columbia is planning to join Ontario in requiring…

Recently it was once again confirmed that physicians who complete regular activities to update their medical knowledge through the…